HIF1A and neoplasm: In this scenario, tumor cells and macrophages activate pro-angiogenic programs mediated by NF-κB-regulated hypoxia inducible factor 1 (HIF-1) that promote tumor cell adaptation and proliferation as well as TAM recruitment and oncogenic activities [72,73].